๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Advanced Clear Cell Renal Cell Carcinoma

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies NCT07195916Phase 122 sites๐Ÿ“ Duarte๐Ÿ“ La Jolla๐Ÿ“ Ann Arbor Incyte Corporation ยท Tests: INCA036873 Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study NCT05361720Phase 26 sites๐Ÿ“ Duarte๐Ÿ“ Orange๐Ÿ“ Cleveland Vanderbilt-Ingram Cancer Center ยท Tests: Cabozantinib, Ipilimumab, Nivolumab Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC) NCT05931393Phase 21 site๐Ÿ“ Dallas University of Texas Southwestern Medical Center ยท Tests: Cabozantinib 80 MG VSV-IFNฮฒ-NIS With Ipilimumab and Nivolumab for the Treatment of Advanced or Metastatic Clear Cell Renal Cell Carcinoma NCT07510334Phase 21 site๐Ÿ“ Rochester Mayo Clinic ยท Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Ipilimumab, Nivolumab Imaging of Solid Tumors Using 18F-TRX NCT06942104Phase 11 site๐Ÿ“ San Francisco Rahul Aggarwal ยท Tests: 18F-TRX, Positron Emission Tomography (PET)/Computerized tomography (CT), Tumor Biopsy, Blood Specimen Collection A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors NCT06764771Phase 18 sites๐Ÿ“ Hackensack๐Ÿ“ Allentown๐Ÿ“ Germantown Bristol-Myers Squibb ยท Tests: BMS-986488, Adagrasib, Cetuximab, Nivolumab A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy NCT06362369Phase 1, Phase 25 sites๐Ÿ“ Aurora๐Ÿ“ Lake Mary๐Ÿ“ Lebanon 7 Hills Pharma, LLC ยท Tests: Alintegimod, Ipilimumab, Nivolumab A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034) NCT07489495Phase 3106 sites๐Ÿ“ Marietta๐Ÿ“ Louisville๐Ÿ“ Louisville Merck Sharp & Dohme LLC ยท Tests: Belzutifan, Zanzalintinib, Placebo A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors NCT07115043Phase 1, Phase 213 sites๐Ÿ“ Grand Rapids๐Ÿ“ St Louis๐Ÿ“ Pittsburgh AstraZeneca ยท Tests: AZD6750, rilvegostomig Radiopharmaceutical Treatment of Advanced Kidney Cancer NCT06783348Phase 22 sites๐Ÿ“ Caen๐Ÿ“ Villejuif European Organisation for Research and Treatment of Cancer โ€ฆ ยท Tests: 177Lu-PSMA-617 Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid Tumors NCT05868174Phase 15 sites๐Ÿ“ North Ryde๐Ÿ“ Adelaide๐Ÿ“ Brisbane Telix Pharmaceuticals (Innovations) Pty Limited ยท Tests: 89Zr-TLX250, 177Lu-TLX250 and Peposertib Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC NCT06863311Phase 25 sites๐Ÿ“ La Jolla๐Ÿ“ Indianapolis๐Ÿ“ St Louis Karie Runcie ยท Tests: XL092, Nivolumab Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma NCT06053658Phase 26 sites๐Ÿ“ Irvine๐Ÿ“ Boston๐Ÿ“ Boston M.D. Anderson Cancer Center ยท Tests: Tivozanib, Nivolumab Phase Ib/II Clinical Study of SHR-8068 Combined Anti-tumor Drugs in the Treatment of Advanced Renal Cell Carcinom NCT07239596Phase 1, Phase 21 site๐Ÿ“ Beijing Suzhou Suncadia Biopharmaceuticals Co., Ltd. ยท Tests: SHR-8068๏ผ›Adebrelimab ๏ผ›Bevacizumab, SHR-8068 ; SHR-4610 Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma NCT05287945Phase 1, Phase 210 sites๐Ÿ“ Orange๐Ÿ“ Palo Alto๐Ÿ“ San Francisco Oncorena AB ยท Tests: Orellanine GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors NCT06265025Phase 1, Phase 24 sites๐Ÿ“ Goyang-si๐Ÿ“ Seoul๐Ÿ“ Seoul GeneMedicine Co., Ltd. ยท Tests: GM103 (Part A), GM103 (Part B), GM103 and Pembrolizumab (Part C) Sapu003 in Advanced mTOR-sensitive Solid Tumors NCT07369505Phase 11 site๐Ÿ“ Adelaide SAPU NANO (US) LLC ยท Tests: Sapu003, Exemestane 25 MG A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208) NCT07293351Phase 1, Phase 295 sites๐Ÿ“ Palo Alto๐Ÿ“ New Haven๐Ÿ“ Washington D.C. Bristol-Myers Squibb ยท Tests: Pumitamig, Ipilimumab, Cabozantinib, Casdatifan Study of DCC-2812 in Participants With Advanced Genitourinary Cancers NCT06966024Phase 18 sites๐Ÿ“ Boston๐Ÿ“ Ann Arbor๐Ÿ“ St Louis Deciphera Pharmaceuticals, LLC ยท Tests: DCC-2812 Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rฮฑ Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer NCT05267626Phase 1, Phase 217 sites๐Ÿ“ Miami๐Ÿ“ Grand Rapids๐Ÿ“ Minneapolis Aulos Bioscience, Inc. ยท Tests: AU-007, Aldesleukin, Avelumab, Nivolumab A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression NCT06682793Phase 1, Phase 210 sites๐Ÿ“ Gilbert๐Ÿ“ La Jolla๐Ÿ“ Los Angeles A2 Biotherapeutics Inc. ยท Tests: A2B395, xT CDx with HLA-LOH assay Digital Monitoring of Self-reported Symptoms by Patients Treated With Cabozantinib Plus Nivolumab for Advanced Clear-cell Renal Carcinoma NCT07028125Phase 419 sites๐Ÿ“ Annecy๐Ÿ“ Avignon๐Ÿ“ Bayeux Centre Francois Baclesse ยท Tests: cabozantinib and nivolumab Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program NCT06265285Phase 21 site๐Ÿ“ Jacksonville Mayo Clinic ยท Tests: Home Health Encounter, Nivolumab, Patient Monitoring, Questionnaire Administration A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV) NCT03592472Phase 338 sites๐Ÿ“ Phoenix๐Ÿ“ Sacramento๐Ÿ“ San Francisco Xynomic Pharmaceuticals, Inc. ยท Tests: Pazopanib, Abexinostat, Placebo A Phase 1 Study of the Safety and Tolerability of CTX-10726 NCT07419841Phase 18 sites๐Ÿ“ Phoenix๐Ÿ“ Jacksonville๐Ÿ“ Rochester Compass Therapeutics ยท Tests: CTX-10726 A Study of IBR854 Combined With Pazopanib Versus Pazopanib in Advanced Renal Cell Carcinoma NCT07087158Phase 21 site๐Ÿ“ Shanghai Imbioray (Hangzhou) Biomedicine Co., Ltd. ยท Tests: IBR854, Pazopanib Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer NCT07383441Phase 341 sites๐Ÿ“ Fayetteville๐Ÿ“ Jonesboro๐Ÿ“ Rogers SWOG Cancer Research Network ยท Tests: Axitinib, Biospecimen Collection, Bone Scan, Cabozantinib, Clostridium butyricum CBM 588 Probiotic Strain Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment NCT05363280Phase 27 sites๐Ÿ“ Birmingham๐Ÿ“ Weston๐Ÿ“ Chicago Advenchen Pharmaceuticals, LLC. ยท Tests: AL8326 40 mg, AL8326 60 mg, AL8326 80 mg--stopped Neoadjuvant Zanzalintinib Plus Nivolumab in Patients With Locally Advanced and/or Inoperable Clear Cell Renal Cell Carcinoma With or Without Non-measurable Metastasis NCT06794229Phase 24 sites๐Ÿ“ St Louis๐Ÿ“ Philadelphia๐Ÿ“ Dallas Qian Qin ยท Tests: Zanzalintinib, Nivolumab Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma NCT06582017Phase 111 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles Nammi Therapeutics Inc ยท Tests: QXL138AM Injection every 2 weeks by IV Infusion
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy